Zubaida Bibi, Cheema Huma Arshad, Hashmi Muhammad Almas, Naeem Muhammad
Medical Genetics Research Laboratory, Department of Biotechnology, Quaid-i-Azam University, Islamabad, Pakistan.
Department of Pediatric Gastroenterology, The Children's Hospital and the Institute of Child Health, Lahore, Pakistan.
Clin Biochem. 2019 Jul;69:30-35. doi: 10.1016/j.clinbiochem.2019.05.012. Epub 2019 May 27.
Inherited unconjugated hyperbilirubinemias are a group of disorders characterized by increased levels of serum unconjugated bilirubin and arise because of the imbalance between its production and elimination from the body. It includes Crigler-Najjar syndrome and Gilbert syndrome. Crigler-Najjar syndrome type 1 represents the extreme severe end of the spectrum with complete absence of hepatic bilirubin uridine diphosphoglucuronate glucuronosyltransferase (UGT1A1). Crigler-Najjar syndrome type 2 patients have intermediate levels of bilirubin owing to incomplete deficiency of UGT1A1, and Gilbert syndrome lies at the extreme mild end of the spectrum with only slightly raised bilirubin level. Here, we present spectrum of UGT1A1 genetic variants in 25 Pakistani children from 23 unrelated families affected with persistent unconjugated hyperbilirubinemias. The promoter region, coding exons and splice junctions of the UGT1A1 were PCR amplified and subjected to Sanger sequencing. Eleven sequence variants were identified underlying disease phenotype including a novel c.582delC variant. Overall, c.622_625dupCAGC was the most frequent variant followed by c.1021C>T found in Crigler-Najjar syndrome type 1 patients. The evaluation of promoter polymorphism A(TA)TAA in the affected children and their families further supported the body of evidence that the A(TA)TAA allele could enhance the effect of other structural variants in Crigler-Najjar syndrome patients. To our knowledge, this is the first comprehensive study on molecular genetics of persistent unconjugated hyperbilirubinemias from Pakistan. This study expands the spectrum of UGT1A1 variants and should help in improved clinical diagnosis, genetic counseling and prenatal diagnosis of the affected families.
遗传性非结合胆红素血症是一组以血清非结合胆红素水平升高为特征的疾病,其发生是由于体内胆红素生成与清除之间的失衡。它包括克里格勒 - 纳贾尔综合征和吉尔伯特综合征。1型克里格勒 - 纳贾尔综合征代表了该疾病谱的极端严重端,其肝胆红素尿苷二磷酸葡萄糖醛酸基转移酶(UGT1A1)完全缺失。2型克里格勒 - 纳贾尔综合征患者由于UGT1A1不完全缺乏,胆红素水平处于中等程度,而吉尔伯特综合征则位于疾病谱的极端轻度端,胆红素水平仅略有升高。在此,我们展示了来自23个无亲缘关系家庭的25名患有持续性非结合胆红素血症的巴基斯坦儿童中UGT1A1基因变异的情况。对UGT1A1的启动子区域、编码外显子和剪接连接进行了聚合酶链反应(PCR)扩增,并进行了桑格测序。共鉴定出11种与疾病表型相关的序列变异,包括一种新的c.582delC变异。总体而言,c.622_625dupCAGC是最常见的变异,其次是在1型克里格勒 - 纳贾尔综合征患者中发现的c.1021C>T。对患病儿童及其家庭中启动子多态性A(TA)TAA的评估进一步支持了以下证据:A(TA)TAA等位基因可增强克里格勒 - 纳贾尔综合征患者中其他结构变异的作用。据我们所知,这是巴基斯坦关于持续性非结合胆红素血症分子遗传学的首次全面研究。该研究扩展了UGT1A1变异谱,应有助于改善受影响家庭的临床诊断、遗传咨询和产前诊断。